MARATTO

article · Nuclear Medicine Review

[18F]FDG PET/CT revealing extensive cutaneous involvement in Sézary syndrome

2025Open accessMohammed V University

Abstract

Sézary syndrome is a rare cutaneous T-cell lymphoma characterized by erythroderma and circulating malignant T cells. This study presents the case of a 31-year-old man with extensive skin involvement detected by 2-deoxy-2-[¹⁸F]fluoro-D-glucose positron emission tomography/computed tomography ([¹⁸F]FDG PET/CT), demonstrating widespread hypermetabolic lesions across the body. In contrast to computed tomography (CT) or magnetic resonance imaging (MRI), which may overlook subtle or millimetric cutaneous lesions, [¹⁸F]FDG PET/CT accurately delineated the extent of disease and provided critical information for staging, therapeutic decision-making, and response assessment. This case underscores the clinical value of [¹⁸F]FDG PET/CT in evaluating extensive cutaneous involvement in Sézary syndrome.

Research topics

  • Cutaneous lymphoproliferative disorders research
  • Cutaneous Melanoma Detection and Management
  • Virus-based gene therapy research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5603/nmr.106872

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.